<DOC>
	<DOCNO>NCT02689778</DOCNO>
	<brief_summary>It estimate approximately 30 % patient diabetes develop diabetic nephropathy . Diabetic nephropathy multifactorial progressive disease occur various mechanism hyperglycemia , oxidative stress , inflammation fibrosis , control block mechanism therefore potential therapeutical target entity . Current treatment option base glycemic control , blood pressure control , well use medication angiotensin-converting enzyme inhibitor Angiotensin II receptor antagonist , action enough stop progression . Pirfenidone drug antifibrotic , antioxidant , anti-inflammatory property . Although specific mechanism unknown , pirfenidone interferes expression , secretion effect β ( TGF-β ) transform growth factor . The investigator plan carry controlled clinical study evaluate effect pirfenidone patient type 2 diabetes nephropathy . The period time treatment administer 12 month , 62 patient include . The primary outcome improvement glomerular filtration rate . The secondary outcome number patient require replacement therapy , 24 hour urine microalbuminuria change concentration TGF - β . Change parameter evaluate end treatment period ( 12 month ) . Throughout study incidence adverse event record , wich allow u learn safety security drug population .</brief_summary>
	<brief_title>Effect Pirfenidone Glomerular Filtration Rate Albuminuria Patients With Diabetic Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Pirfenidone</mesh_term>
	<criteria>Inclusion criterion Body mass index ( BMI ) less 35 kg/m2 Diagnosis diabetes mellitus type 2 Glomerular filtration rate 1589 ml/min Albuminuria ≥30 mg/24 h &lt; 3.5 g/24 h Individuals blood pressure le 140/90 mmHg treat stable dos antihypertensive drug . Glycated hemoglobin &lt; 10 % Exclusion criteria Another etiology renal disease ( autoimmune disease , polycystic kidney disease ) Repeated urinary tract infection ( three episode past year ) Photosensitivity drug Liver disease Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pirfenidone</keyword>
	<keyword>Diabetic nephropathy</keyword>
</DOC>